Eli Lilly's chief executive, chairman and president John Lechleiter is to step down in December, and will be replaced David Ricks, who currently leads the company’s bio-medicines division.

In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West ... His predecessor, John ...

Eli Lilly has a long, proud history that begins ... In 2009 the company’s then-CEO John Lechleiter and his leadership team ...

Eli Lilly’s new CEO, David Ricks, has announced a revamp of the company’s structure and leadership as he takes the reins. Ricks took over this month from the retiring John Lechleiter ...